Evaluation of STANDARD TM M10 SARS-CoV-2, a Novel Cartridge-Based Real-Time PCR Assay for the Rapid Identification of Severe Acute Respiratory Syndrome Coronavirus 2.

Autor: Grumiro, Laura, Brandolini, Martina, Gatti, Giulia, Scalcione, Agata, Taddei, Francesca, Dirani, Giorgio, Mancini, Andrea, Denicolò, Agnese, Manera, Martina, Zannoli, Silvia, Marino, Maria Michela, Morotti, Manuela, Arfilli, Valentina, Battisti, Arianna, Cricca, Monica, Sambri, Vittorio
Předmět:
Zdroj: Applied Microbiology (2673-8007); Dec2022, Vol. 2 Issue 4, p873-881, 9p
Abstrakt: Since the beginning of the pandemic, SARS-CoV-2 has caused problems for all of world's population, not only in terms of deaths but also in terms of overloading healthcare facilities in all countries. Diagnosis is one of the key aspects of controlling the spread of SARS-CoV-2, and among the current molecular techniques, real-time PCR is considered as the gold standard. The availability of tests that allow for the rapid and accurate identification of SARS-CoV-2 is therefore of considerable importance. Moreover, if these tests allow for even minimal intervention by the operator, any risk of contamination is reduced. In this study, the performances of the new STANDARDTM M10 SARS-CoV-2 (SD Biosensor Inc., Suwon, Korea) rapid molecular test, which incorporates the above-mentioned features, were characterized. The clinical and analytical performances measured by testing different variants circulating in Italy of STANDARDTM M10 SARS-CoV-2 were compared to the test already on the market and recognized as the gold standard: Xpert Xpress SARS-CoV-2 (Cepheid, Sunnyvale, CA, USA). The results obtained between the two tests are largely comparable, suggesting that STANDARDTM M10 SARS-CoV-2 can be used with excellent results in the fight against the global spread of SARS-CoV-2. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje